245 related articles for article (PubMed ID: 2525493)
1. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
2. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
3. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
4. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
6. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
McCormack AJ; Hak LJ; Finn WF
Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
[TBL] [Abstract][Full Text] [Related]
7. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG
Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427
[TBL] [Abstract][Full Text] [Related]
8. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
Cohen MP
Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
Cohen MP; Klepser H; Wu VY
Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase and the development of renal disease in diabetic dogs.
Kern TS; Engerman RL
J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
[TBL] [Abstract][Full Text] [Related]
13. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
[TBL] [Abstract][Full Text] [Related]
14. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
15. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
Kassab JP; Guillot R; Andre J; Claperon N; Bellon G; Feldmann G; Peyroux J; Sternberg M
Biochem Pharmacol; 1994 Aug; 48(5):1003-8. PubMed ID: 8093087
[TBL] [Abstract][Full Text] [Related]
16. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
Das A; Frank RN; Zhang NL
Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806
[TBL] [Abstract][Full Text] [Related]
17. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
[TBL] [Abstract][Full Text] [Related]
18. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
[TBL] [Abstract][Full Text] [Related]
19. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
